People: Achieve Life Sciences Inc (ACHV.OQ)

ACHV.OQ on NASDAQ Stock Exchange Capital Market

10:20pm IST
Change (% chg)

$-0.13 (-8.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bencich, John 

Mr. John A. Bencich serves as Chief Financial Officer, Chief Operating Officer, Executive Vice President of the Company. Mr. Bencich joined us from Integrated Diagnostics, Inc., a molecular diagnostics company, where he served as Chief Financial Officer from September 2012 to August 2014. Prior to joining Integrated Diagnostics, he served as Chief Financial Officer of Allozyne, Inc. since July, 2011. Mr. Bencich was an independent consultant from November 2010 until he joined Allozyne. He served as the Vice President, Chief Financial Officer and Treasurer of Trubion Pharmaceuticals, Inc., a biotechnology company, from November 2009 until its acquisition by Emergent BioSolutions Inc. in October 2010. Mr. Bencich served as Trubion’s Senior Director of Finance and Accounting from May 2007 through November 2009. From September 2004 to April 2007, Mr. Bencich was an employee of Onyx Software Corporation, a software company, where he last served as Director of Finance and Corporate Controller. From 1999 to 2004, Mr. Bencich was an employee of Ernst & Young LLP, an international professional services firm, where he last served as a manager. Mr. Bencich received a B.A. in Accountancy from the University of San Diego and an M.B.A. from Seattle University. Mr. Bencich received his Certified Public Accountant Certification from the State of Washington and currently holds an active license.

Basic Compensation

Total Annual Compensation, USD 410,833
Restricted Stock Award, USD 158,372
Long-Term Incentive Plans, USD --
All Other, USD 574,696
Fiscal Year Total, USD 1,143,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Stewart


Anthony Clarke


John Bencich


Cindy Jacobs


Scott Cormack


Donald Joseph

As Of  31 Dec 2017